TRANSFORMED LYMPHOMA
Clinical trials for TRANSFORMED LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new TRANSFORMED LYMPHOMA trials appear
Sign up with your email to follow new studies for TRANSFORMED LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New strategy aims to stop aggressive lymphoma from coming back
Disease control Recruiting nowThis study is testing whether adding a maintenance drug called acalabrutinib after cellular therapies (like stem cell transplants or CAR-T cell therapy) can help prevent aggressive lymphoma from returning in patients at very high risk of relapse. Researchers want to see if this e…
Matched conditions: TRANSFORMED LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Fighting cancer with re-engineered immune cells: early trial seeks to tame tough lymphomas
Disease control Recruiting nowThis is an early-stage study testing the safety of a personalized cell therapy for adults with specific types of non-Hodgkin lymphoma that have come back or not responded to standard treatments. Doctors will modify a patient's own immune cells to better target and fight their can…
Matched conditions: TRANSFORMED LYMPHOMA
Phase: PHASE1 • Sponsor: C. Babis Andreadis • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC